Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway

Overview of attention for article published in Frontiers in Pharmacology, April 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 792 followers.

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway ... https://t.co/qH0bhrpRcG

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway ... https://t.co/qH0bhrpRcG

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.